290 related articles for article (PubMed ID: 38391963)
21. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.
Fedele M; Sgarra R; Battista S; Cerchia L; Manfioletti G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054987
[TBL] [Abstract][Full Text] [Related]
22. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
[TBL] [Abstract][Full Text] [Related]
23. ΔNp63 is regulated by insulin/IGF-1 signaling in normal basal/progenitor mammary cells and in luminal-type breast cancer cells.
Stenckova M; Liu Y; Nekulova M; Holcakova J; Pokorna Z; Nenutil R; Thompson AM; Vojtesek B; Coates PJ
Neoplasma; 2023 Oct; 70(5):621-632. PubMed ID: 38053383
[TBL] [Abstract][Full Text] [Related]
24. The β
Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
[TBL] [Abstract][Full Text] [Related]
25. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.
Wang S; Zheng Y; Yang F; Zhu L; Zhu XQ; Wang ZF; Wu XL; Zhou CH; Yan JY; Hu BY; Kong B; Fu DL; Bruns C; Zhao Y; Qin LX; Dong QZ
Signal Transduct Target Ther; 2021 Jul; 6(1):249. PubMed ID: 34219130
[TBL] [Abstract][Full Text] [Related]
26. RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer.
Brady L; Nelson PS
J Endocrinol; 2023 Feb; 256(2):. PubMed ID: 36286645
[TBL] [Abstract][Full Text] [Related]
27. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Fernandes RC; Toubia J; Townley S; Hanson AR; Dredge BK; Pillman KA; Bert AG; Winter JM; Iggo R; Das R; Obinata D; ; Sandhu S; Risbridger GP; Taylor RA; Lawrence MG; Butler LM; Zoubeidi A; Gregory PA; Tilley WD; Hickey TE; Goodall GJ; Selth LA
Cell Rep; 2021 Jan; 34(1):108585. PubMed ID: 33406413
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
Creighton CJ; Chang JC; Rosen JM
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
31. Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy.
Bando Y; Kobayashi T; Miyakami Y; Sumida S; Kakimoto T; Saijo Y; Uehara H
J Med Invest; 2021; 68(3.4):213-219. PubMed ID: 34759133
[TBL] [Abstract][Full Text] [Related]
32. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
Akamatsu S; Inoue T; Ogawa O; Gleave ME
Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
[TBL] [Abstract][Full Text] [Related]
34. Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention.
Nouri M; Ratther E; Stylianou N; Nelson CC; Hollier BG; Williams ED
Front Oncol; 2014; 4():370. PubMed ID: 25566507
[TBL] [Abstract][Full Text] [Related]
35. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Prat A; Parker JS; Karginova O; Fan C; Livasy C; Herschkowitz JI; He X; Perou CM
Breast Cancer Res; 2010; 12(5):R68. PubMed ID: 20813035
[TBL] [Abstract][Full Text] [Related]
37. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
38. Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer.
Zamora I; Freeman MR; Encío IJ; Rotinen M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761978
[TBL] [Abstract][Full Text] [Related]
39. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
Dong B; Miao J; Wang Y; Luo W; Ji Z; Lai H; Zhang M; Cheng X; Wang J; Fang Y; Zhu HH; Chua CW; Fan L; Zhu Y; Pan J; Wang J; Xue W; Gao WQ
Commun Biol; 2020 Dec; 3(1):778. PubMed ID: 33328604
[TBL] [Abstract][Full Text] [Related]
40. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion.
Petersen OW; Lind Nielsen H; Gudjonsson T; Villadsen R; Rønnov-Jessen L; Bissell MJ
Breast Cancer Res; 2001; 3(4):213-7. PubMed ID: 11434871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
